Salicylic acid plant ramp-up delays
The salicylic acid plant is still in stabilization; delays in achieving 800 tons/month breakeven could pressure margins.
AARTIDRUGS / Q2-FY26 / risks
Keep the risk register visible.
Aarti Drugs · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
high
Domestic antibiotic demand weakness
Domestic demand, especially in antibiotics, remained soft with slight degrowth; recovery expected only from Q4.
Pricing pressure on methylamines
Management acknowledged potential price erosion as new methylamine capacity comes online, which could impact margins.
Tarapur plant closure risk
Voluntary closure of chlorosulfonation process at Tarapur due to gas leak; though no material impact currently, regulatory delays could affect operations.